
Eyecelerator @ AAO 2025
Register Now: Oct. 16 | Orlando, FL
CONFERENCE SPEAKERS

Alcon
Laurent Attias
SVP Corporate Strategy, BD&L and M&A

CBER, FDA
Heidi I. Becker, MD
Ophthalmology Clinical Reviewer

Glaukos
Thomas W. Burns
Chairman & CEO

The Chinese University of Hong Kong
Carol Y. Cheung, PhD
Professor, Department of Ophthalmology & Visual Sciences

Ocular Therapeutix
Pravin U. Dugel, MD
President & CEO

Leerink Partners
Andrew Gitkin
Senior Managing Director

Wills Eye Hospital
Julia A. Haller, MD
Ophthalmologist-in-Chief

Wills Eye Hospital
Allen C. Ho, MD
Director of Retina Research

Market Scope
Kristen Harmon Ingenito, MBA
CEO

Washington University School of Medicine
Aaron Y. Lee, MD
Arthur W. Stickle Distinguished Professor and Chair

Alcon
Franck Leveiller, PhD
Chief Scientific Officer and SVP, Head Global Research & Development

American Academy of Ophthalmology
Stephen D. McLeod, MD
CEO​

Intuitive | Sonder Capital
Frederic Moll, MD, MS
Co-Founder | Co-Founder & Partner

Glaukos​​
Tomas Navratil, PhD
Chief Development Officer

ExSight Ventures, LLC
Firas M. Rahhal, MD
Partner

Microsoft
David Rhew, MD
Global CMO and Vice President of Healthcare

Minnesota Eye Consultants
Thomas W. Samuelson, MD
Founding Partner

Ocular Therapeutix, Inc.
Namrata Saroj, OD
Chief Business Officer

Wills Eye Hospital
Joel S. Schuman, MD
Professor and Vice Chair for Research Innovation

Stanford Medicine​
Kuldev Singh, MD, MPH
Professor of Ophthalmology

Topcon Healthcare, Inc. | Alliance for Healthcare from the Eye
Ali Tafreshi
CEO and President | Founding Member

Vance Thompson Vision
Vance M. Thompson, MD
Founder​​

AbbVie
Ramin Valian
VP, Eyecare Global Pipeline and Commercial Strategy

PROCEPT BioRobotics
Reza Zadno, PhD
Former President & CEO​

California Retina Consultants
Robert L. Avery, MD
Founder/CEO

Morgan Stanley
Neha Begwani, MBA
Managing Director, Healthcare Investment

ForSight Robotics
David F. Chang, MD
Chair, Clinical Advisory Board

Glaukos
Robert L. Davis, JD
SVP, General Counsel & Business Development
​

Glaukos
Joseph E. Gilliam
President & COO

EyeBio, A Subsidiary of Merck & Co., Inc.
David R. Guyer, MD
CEO

Visionary Ventures
Garrett Hamontree, MBA
Partner

Horizon Surgical System
Jean-Pierre Hubschman, MD
Co-Founder and CEO

InterWest Partners​
Gil Kliman, MD
Managing Partner

Washington University School of Medicine
Cecilia S. Lee, MD, MS
​Professor of Ophthalmology

Neurotech Pharmaceuticals, Inc.
James V. Mazzo
Executive Chair
​

Roche Pharma
Esther Melo, PhD
BD&L Director, Partnering

ExSight Ventures, LLC
James C. Murray, JD
Founder and Managing Member

Johnson & Johnson Surgical Vision
Erin Powers, MBA
President

See Clearly Vision Group
Rajesh K. Rajpal, MD
Founder

CDER, FDA
Shilpa D. Rose, MD
Ophthalmology Clinical Reviewer

Astellas Pharma
Peter Sandor, MD, MBA
EVP Head of Corporate Strategy

University of California
Julie M. Schallhorn, MD, MS
​Professor

Jefferson EyeBrain Center
Robert C. Sergott, MD
Executive Director

Mass Eye and Ear, Mass General Brigham
Rishi P. Singh, MD
Incoming Chair, Department of Ophthalmology

CDRH, FDA
​
Michelle E. Tarver, MD, PhD
Center Director

Duke University
Lejla Vajzovic, MD
Associate Professor of Ophthalmology

Retina Consultants of Texas
Charles C. Wykoff, MD, PhD
Surgical Retinal Specialist

Samsara BioCapital
Roger Zhang, PhD
Vice President